AGENUS INC Preferred Stock, Shares Authorized
AGENUS INC (AGEN) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-07
- 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2024-12-31: Preferred Stock, Shares Authorized 5.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 5.00M shares 10-Q · filed 2026-08-07 |
| 2026-03-31 | 5.00M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 5.00M shares 10-Q · filed 2026-08-07 |
| 2024-12-31 | 5.00M shares 10-K · filed 2026-03-16 |
| 2023-12-31 | 5.00M shares 10-K · filed 2025-03-17 |
| 2022-12-31 | 5.00M shares 10-K · filed 2024-03-14 |
| 2021-12-31 | 5.00M shares 10-K · filed 2023-03-16 |
| 2021-09-30 | 5.00M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 5.00M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 5.00M shares 10-Q · filed 2021-05-07 |
| 2020-12-31 | 5.00M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 5.00M shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 5.00M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 5.00M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 5.00M shares 10-K · filed 2021-03-16 |
| 2019-09-30 | 5.00M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 5.00M shares 10-Q · filed 2019-08-09 |
| 2019-03-31 | 5.00M shares 10-Q · filed 2019-05-10 |
| 2018-12-31 | 5.00M shares 10-K · filed 2020-03-16 |
| 2018-09-30 | 5.00M shares 10-Q · filed 2018-11-07 |
| 2018-06-30 | 5.00M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 5.00M shares 10-Q · filed 2018-05-10 |
| 2017-12-31 | 5.00M shares 10-K · filed 2019-03-18 |
| 2017-09-30 | 5.00M shares 10-Q · filed 2017-11-07 |
| 2017-06-30 | 5.00M shares 10-Q · filed 2017-08-07 |
| 2017-03-31 | 5.00M shares 10-Q · filed 2017-05-04 |
| 2016-12-31 | 5.00M shares 10-K · filed 2018-03-16 |
| 2016-09-30 | 5.00M shares 10-Q · filed 2016-11-09 |
| 2016-06-30 | 5.00M shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 5.00M shares 10-Q · filed 2016-05-09 |
| 2015-12-31 | 5.00M shares 10-K · filed 2017-03-16 |
| 2015-09-30 | 5.00M shares 10-Q · filed 2015-11-04 |
| 2015-06-30 | 5.00M shares 10-Q · filed 2015-08-03 |
| 2015-03-31 | 5.00M shares 10-Q · filed 2015-05-01 |
| 2014-12-31 | 5.00M shares 10-K · filed 2016-03-15 |
| 2014-09-30 | 5.00M shares 10-Q · filed 2014-10-31 |
| 2014-06-30 | 5.00M shares 10-Q · filed 2014-08-01 |
| 2014-03-31 | 5.00M shares 10-Q · filed 2014-05-09 |
| 2013-12-31 | 5.00M shares 10-K · filed 2015-03-16 |
| 2013-09-30 | 5.00M shares 10-Q · filed 2013-11-08 |
| 2013-06-30 | 5.00M shares 10-Q · filed 2013-08-09 |
| 2013-03-31 | 5.00M shares 10-Q · filed 2013-05-10 |
| 2012-12-31 | 5.00M shares 10-K · filed 2014-03-07 |
| 2012-09-30 | 5.00M shares 10-Q · filed 2012-11-07 |
| 2012-06-30 | 5.00M shares 10-Q · filed 2012-08-08 |
| 2012-06-15 | 25.00M shares 10-K · filed 2014-03-07 |
| 2012-03-31 | 25.00M shares 10-Q · filed 2012-05-09 |
| 2011-12-31 | 25.00M shares 10-K · filed 2013-03-18 |
| 2011-09-30 | 25.00M shares 10-Q · filed 2011-11-04 |
| 2011-06-30 | 25.00M shares 10-Q · filed 2011-08-05 |
| 2010-12-31 | 25.00M shares 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |